Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $796.15 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $234.14 | 2 | $0 (2019) |
| Greenwich Biosciences, Inc. | $153.55 | 2 | $0 (2019) |
| Neurocrine Biosciences, Inc. | $124.99 | 1 | $0 (2019) |
| SK Life Science, Inc. | $121.92 | 1 | $0 (2020) |
| Amgen Inc. | $121.60 | 1 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $17.17 | 1 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $11.88 | 1 | $0 (2019) |
| PFIZER INC. | $10.90 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $121.60 | 1 | Amgen Inc. ($121.60) |
| 2020 | $121.92 | 1 | SK Life Science, Inc. ($121.92) |
| 2019 | $462.73 | 7 | Greenwich Biosciences, Inc. ($153.55) |
| 2018 | $89.90 | 1 | Genentech USA, Inc. ($89.90) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/29/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Neuroscience | ||||||
| 10/29/2020 | SK Life Science, Inc. | Cenobamate (Drug) | Food and Beverage | In-kind items and services | $121.92 | General |
| Category: Neurology | ||||||
| 12/18/2019 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Neurology | ||||||
| 10/23/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: NEUROLOGY | ||||||
| 10/22/2019 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Food and Beverage | In-kind items and services | $137.34 | General |
| Category: Neurology | ||||||
| 09/13/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $10.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/16/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Central Nervous System | ||||||
| 03/12/2019 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $144.24 | General |
| Category: Metabolism & Primary Care | ||||||
| 01/10/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.88 | General |
| Category: Cardiovascular | ||||||
| 11/08/2018 | Genentech USA, Inc. | Activase (Biological) | Food and Beverage | In-kind items and services | $89.90 | General |
| Category: Metabolism & Primary Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 267 | 334 | $110,292 | $39,352 |
| 2022 | 5 | 129 | 144 | $52,395 | $19,257 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 73 | 120 | $27,480 | $11,699 | 42.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 47 | 47 | $20,398 | $6,514 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 38 | 38 | $15,808 | $5,510 | 34.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 34 | 39 | $9,009 | $4,680 | 51.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 25 | 26 | $23,452 | $4,653 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 25 | $5,925 | $2,679 | 45.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $4,270 | $1,949 | 45.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 25 | $3,950 | $1,667 | 42.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 42 | 55 | $12,595 | $4,674 | 37.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 25 | $10,850 | $4,125 | 38.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 20 | 20 | $8,320 | $3,407 | 41.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 19 | $5,795 | $2,803 | 48.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 13 | 14 | $12,294 | $2,789 | 22.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 11 | 11 | $2,541 | $1,459 | 57.4% |
About Dr. Shakaib Qureshi, MD
Dr. Shakaib Qureshi, MD is a Neurology healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2017. The National Provider Identifier (NPI) number assigned to this provider is 1982126512.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shakaib Qureshi, MD has received a total of $796.15 in payments from pharmaceutical and medical device companies, with $121.60 received in 2021. These payments were reported across 10 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($796.15).
As a Medicare-enrolled provider, Qureshi has provided services to 396 Medicare beneficiaries, totaling 478 services with total Medicare billing of $58,609. Data is available for 2 years (2022–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Hartford, CT
- Active Since 07/14/2017
- Last Updated 08/19/2022
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1982126512
Products in Payments
- Activase (Biological) $234.14
- Epidiolex (Drug) $153.55
- INGREZZA (Drug) $124.99
- Cenobamate (Drug) $121.92
- Aimovig (Biological) $121.60
- ELIQUIS (Drug) $22.78
- AJOVY (Drug) $17.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Hartford
Dr. Tapan Mehta, M.b.b.s, M.B.B.S
Neurology — Payments: $31,259
Dr. Lawrence Bluth, M.d, M.D
Neurology — Payments: $14,628
Dr. Stephen Conway, M.d, M.D
Neurology — Payments: $11,972
Dr. Brian Wong, M.d, M.D
Neurology — Payments: $8,026
Keshav Rao, Md, MD
Neurology — Payments: $3,525
Alexis Demopoulos, Md, MD
Neurology — Payments: $3,008